Bioengineering Research Grants (R01 Clinical Trial Optional)
This grant supports small multidisciplinary teams using bioengineering approaches to develop and advance innovative tools or methods for solving biomedical research or clinical problems.
Funder: National Institutes of Health
Due Dates: July 5, 2029: Full application deadline
Funding Amounts: Up to $500,000 per award; project period and total funding may vary by application.
Summary: Supports multidisciplinary bioengineering research that integrates life and physical sciences to address biomedical problems, including translational and clinical applications.
Description
This funding opportunity supports collaborations between life and physical sciences that use multidisciplinary bioengineering approaches to solve biomedical problems. The program seeks projects that integrate, optimize, validate, translate, or accelerate the adoption of promising tools, methods, and techniques for research or clinical challenges in basic, translational, or clinical science. Eligible projects may include design-directed, developmental, discovery-driven, or hypothesis-driven research, and are particularly suited for small teams using integrative approaches to advance understanding and solutions in biological, clinical, or translational science.
The program will support clinical trials that test functionality or validate performance in a relevant setting, but it is not intended for conventional clinical trials where translation is not the primary motivation. Phase III clinical trials and commercial production are not supported.
